Functional characterization of receptor‐type protein tyrosine phosphatase CD148 (HPTPη/DEP‐1) in Fcγ receptor IIa signal transduction of human neutrophils
- 5 December 1997
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 27 (12) , 3532-3535
- https://doi.org/10.1002/eji.1830271255
Abstract
Activation of the 40‐kDa low‐affinity receptor for IgG (FcγRIIa, CD32) leads to tyrosine phosphorylation, increase of cytosolic free calcium concentration ([Ca2+]i), and production of superoxide anions (O2−) in neutrophils (PMN). It has been established that protein tyrosine kinases (PTK) and phosphatases (PTP) are essential for the regulation of intracellular signaling. CD45 is a type I receptor‐type protein tyrosine phosphatase (RPTP) with two PTP domains. Recently it has been demonstrated that co‐cross‐linking of CD45 modulates the signal transduction pathway of FcγRIIa in PMN. In contrast, the functional characteristics of CD148 (HPTPη/DEP‐1), a new RPTP with only one PTP domain, is unknown. CD148 is expressed on PMN in slightly lower density than CD45, and in higher density than on lymphocytes. [Ca2+]i measured with fluo‐3‐loaded PMN by flow cytometry and O2− production determined by lucigenin‐dependent chemiluminescence were inhibited by co‐cross‐linking of CD45 with FcγRIIa in comparison to isotype control monoclonal antibody (mAb). In contrast, preincubation with CD148 mAb 143‐41 abolished O2− generation, but did not inhibit [Ca2+]i rise. In summary, both clustered human RPTP, CD45 and CD148, inhibit FcγRIIa‐induced O2− production in PMN, but they differ in regulation of [Ca2+]i. Therefore, it is suggested that co‐cross‐linking of FcγRII with CD45 and CD148 leads to dephosphorylation of different substrates. These distinct functional capacities may be important for differential regulation of FcγR signaling by currently unknown ligands.Keywords
This publication has 17 references indexed in Scilit:
- The Receptor-like Protein-tyrosine Phosphatase DEP-1 Is Constitutively Associated with a 64-kDa Protein Serine/ Threonine KinasePublished by Elsevier ,1997
- Clinical significance of IgG Fc receptors and FcγR-directed immunotherapiesImmunology Today, 1997
- Cloning and Characterization of Rat Density-Enhanced Phosphatase-1, a Protein Tyrosine Phosphatase Expressed by Vascular CellsCirculation Research, 1996
- Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient MiceImmunity, 1996
- Molecular cloning and characterization of Byp, a murine receptor‐type tyrosine phosphatase similar to human DEP‐1FEBS Letters, 1996
- Function of human FcγRIIA and FcγRIIIBSeminars in Immunology, 1995
- The Role of Protein Tyrosine Phosphatases in Lymphocyte Activation and DifferentiationCritical Reviews in Immunology, 1994
- Fcγ receptor activation of neutrophils in cryoglobulin-induced leukocytoclastic vasculitisArthritis & Rheumatism, 1993
- The glycosylphosphatidylinositol‐linked Fcγ receptor III represents the dominant receptor structure for immune complex activation of neutrophilsEuropean Journal of Immunology, 1992
- Identification of a second class of IgG Fc receptors on human neutrophils. A 40 kilodalton molecule also found on eosinophils.The Journal of Experimental Medicine, 1986